iThe current values are delayed, open demat account for live values.
Nifty50 Value 20
Nifty50 Value 20 Performance
-
Open
11,606.60
-
High
11,625.60
-
Low
11,528.60
-
Prev Close
11,739.85
-
Dividend Yeild
2.09%
-
P/E
15.62
Other Indices
| Indices Name | Price | Price Change (% change) |
|---|---|---|
| India VIX | 26.0475 | 1.04 (4.15%) |
| Nifty 10 Yr Benchmark G-Sec | 2,571.24 | -11.71 (-0.45%) |
| Nifty 10 Yr Benchmark G-Sec (Clean Price) | 862.46 | -4.05 (-0.47%) |
| Nifty 100 | 22,837.65 | -435.1 (-1.87%) |
| Nifty 100 Alpha 30 Index | 15,784.05 | -410.25 (-2.53%) |
Constituent Companies
| Company | Market Cap | Market Price | Volume | Sector |
|---|---|---|---|---|
| Cipla Ltd | ₹96,603 Cr |
₹1,186.2
(1.34%)
|
18,58,127 | Pharmaceuticals |
| Hindalco Industries Ltd | ₹2,03,284 Cr |
₹902.75
(0.55%)
|
68,36,471 | Non Ferrous Metals |
| ITC Ltd | ₹3,65,109 Cr |
₹292.4
(4.92%)
|
2,66,26,729 | Tobacco Products |
| Tata Motors Passenger Vehicles Ltd | ₹1,11,539 Cr |
₹297.05
(1.98%)
|
1,09,97,326 | Automobile |
| Wipro Ltd | ₹2,00,486 Cr |
₹192
(3.13%)
|
1,64,12,269 | IT - Software |
Nifty50 Value 20 Chart
More About Nifty50 Value 20
Nifty50 Value 20 HeatmapLatest News
- Apr 02, 2026
Bank Nifty advanced 3.04% to hit an intraday high of 51,806.25 on April 1, ending a two-session decline as banking stocks moved higher alongside a sharp rebound in benchmark indices.
- Apr 02, 2026
Shipping and logistics stocks advanced by up to 7% on April 2 after signals of a possible de-escalation in the West Asia conflict improved market sentiment and reduced concerns around global trade disruptions.
Latest Blogs
Catch the latest Sensex Nifty updates as the markets swing with changing global trends, domestic cues, and sector performances. Follow how India’s benchmark indices are shaping the trading day.
- Apr 01, 2026
Indian markets surged sharply, with the Sensex rising 1.65% and Nifty gaining 1.56%, led by strong momentum in banking and broad-based buying across sectors. Stocks like Trent, InterGlobe Aviation, and Adani group names drove gains, while pharma lagged. Global cues remained highly supportive, with strong rallies across Asian and European markets. In the previous session, U.S.
- Mar 30, 2026
